The vital role the European Monitoring Centre for Drugs and Drug Addiction plays in the UK’s ability to respond to illicit drugs and organised crime

Abstract

Much attention has been devoted to the consequences of the European Medicines Agency’s departure from London because of Brexit. Yet exclusion from other EU agencies, including the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), will also have serious consequences for public health in the United Kingdom.

Publication
BMJ
Date